Natalie Czepiel

Natalie Czepiel is a Senior Associate Scientist at Atalanta Therapeutics, specializing in in-vivo neurobiology since March 2022. Previously, Natalie served as an Associate Scientist at Sanofi, focusing on complement biology research from February 2021 to March 2022. Earlier experience includes an Undergraduate Research Assistant role at the University of New Hampshire, where Natalie coordinated an independent study on cannabinoid receptor 1 signaling in mice and optimized western blotting protocols. Natalie holds a Bachelor of Science degree in Neuroscience and Behavior from the University of New Hampshire, obtained in 2020.